Dynamic Contrast Enhancement of Experimental Glioma. An Intra-individual Comparative Study to Assess the Optimal Time Delay

Academic Radiology

Volumn 17, Issue 2, 2010, Pages 188-193

  Engelhorn, Tobias ^a   Schwarz, Marc A ^a   Eyupoglu, Ilker Y ^a   Kloska, Stephan P ^a   Struffert, Tobias ^a   Doerfler, Arnd ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

3 Tesla; contrast media; Glioma; MRI; rat

Indexed keywords

GADOBENATE DIMEGLUMINE; GADOBUTROL; GADOLINIUM PENTETATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; CONTRAST TO NOISE RATIO; CONTROLLED STUDY; DRUG UPTAKE; GLIOMA; GLIOMA CELL; HISTOLOGY; MATHEMATICAL PARAMETERS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; SIGNAL NOISE RATIO; TUMOR VOLUME;

ANIMALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CONTRAST MEDIA; DRUG ADMINISTRATION SCHEDULE; GADOLINIUM; GLIOMA; HUMANS; IMAGE ENHANCEMENT; NEOPLASMS, EXPERIMENTAL; RATS; RATS, INBRED F344; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 73049103158     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acra.2009.08.014     Document Type: Article

References (19)

1. Trattnig S., Ba-Ssalamah A., Noebauer-Huhmann I.M., et al. MR contrast agent at high-field MRI (3 Tesla). Top Magn Reson Imaging 14 (2003) 365-375
2. Albert F.K., Forsting M., Sartor K., et al. Early postoperative magnetic resonance imaging of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 34 (1994) 45-60
3. Schneider G., Kirchin M.A., Pirovano G., et al. Gadobenate dimeglumine-enhanced magnetic resonance imaging of intracranial metastases: effect of dose on lesion detection and delineation. J Magn Reson Imaging 14 (2001) 525-539
4. Ba-Ssalamah A., Nöbauer-Huhmann I.M., Pinker K., et al. Effect of contrast dose and field strength in the magnetic resonance detection of brain metastases. Invest Radiol 38 (2003) 415-422
5. Erickson B.J., Campeau N.G., Schreiner S.A., et al. Triple-dose contrast/magnetization transfer suppressed imaging of "non-enhancing" brain gliomas. J Neurooncol 60 (2002) 25-29
6. Runge V.M., Parker J.R., and Donovan M. Double-blind, efficacy evaluation of gadobenate dimeglumine, a gadolinium chelate with enhanced relaxivity, in malignant lesions of the brain. Invest Radiol 37 (2002) 269-280
7. Engh J.A., Flickinger J.C., Niranjan A., et al. Optimizing intracranial metastasis detection for stereotactic radiosurgery. Stereotact Funct Neurosurg 85 (2007) 162-168
8. Reifenberger G., Bilzer T., Seitz R.J., et al. Expression of vimentin and glial fibrillary acidic protein in ethylnitrosourea-induced rat gliomas and glioma cell lines. Acta Neuropathol 78 (1989) 270-282
9. Barth R.F. Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas. J Neurooncol 36 (1998) 91-102
10. Wintersperger B.J., Runge V.M., Biswas J., et al. Brain tumor enhancement in MR imaging at 3 Tesla. Comparison of SNR and CNR gain using TSE and GRE techniques. Invest Radiol 42 (2007) 558-563
11. Kim B., Chenevert T.L., and Ross B.D. Growth kinetics and treatment response of the intracerebral rat 9L brain tumor model: a quantitative in vivo study using magnetic resonance imaging. Clin Cancer Res 1 (1995) 643-650
12. Berens M.E., and Giese A. "Those left behind." Biology and oncology of invasive glioma cells. Neoplasia 1 (1999) 208-219
13. von Deimling A., Louis D.N., and Wiestler O.D. Molecular pathways in the formation of gliomas. Glia 15 (1995) 328-338
14. Pinkernelle J., Teichgraeber U., Neumann F., et al. Imaging of single human carcinoma cells in vitro using a clinical whole-body magnetic resonance scanner at 3.0 T. Magn Reson Med 53 (2005) 1187-1192
15. Barth R.F. Rat brain tumor models in experimental neurooncology: the 9L, C6, F98, RG2 (D74), RT-2 and CNS-1 gliomas. J Neurooncol 36 (1998) 91-102
16. Runge V.M., Biswas J., Wintersperger B.J., et al. The efficacy of gadobenate dimeglumine (Gd-BOPTA) at 3 Tesla in brain magnetic resonance imaging: comparison to 1.5 Tesla and a standard gadolinium chelate using a rat brain tumor model. Invest Radiol 41 (2006) 244-248
17. Yrjänä S.K., Vaara T., Karttunen A., et al. Pulse repetition time and contrast enhancement: simulation study of Gd-BOPTA and conventional contrast agent at different field strengths. Invest Radiol 43 (2008) 267-275
18. Rohrer M., Bauer H., Mintorovitch J., et al. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 40 (2005) 715-724
19. Vonarbourg A., Sapin A., Lemaire L., et al. Characterization and detection of experimental rat gliomas using magnetic resonance imaging. MAGMA 17 (2004) 133-139